Literature DB >> 22180708

Systematic review of health-related quality of life after esophagectomy for esophageal cancer.

Marco Scarpa1, Stefano Valente, Rita Alfieri, Matteo Cagol, Giorgio Diamantis, Ermanno Ancona, Carlo Castoro.   

Abstract

This study is aimed to assess the long-term health-related quality of life (HRQL) of patients after esophagectomy for esophageal cancer in comparison with established norms, and to evaluate changes in HRQL during the different stages of follow-up after esophageal resection. A systematic review was performed by searching medical databases (Medline, Embase and the Cochrane Library) for potentially relevant studies that appeared between January 1975 and March 2011. Studies were included if they addressed the question of HRQL after esophageal resection for esophageal cancer. Two researchers independently performed the study selection, data extraction and analysis processes. Twenty-one observational studies were included with a total of 1282 (12-355) patients. Five studies were performed with short form-36 (SF-36) and 16 with European Organization for Research and Treatment of Cancer (EORTC) QLQ C30 (14 of them also utilized the disease-specific OES18 or its previous version OES24). The analysis of long-term generic HRQL with SF-36 showed pooled scores for physical, role and social function after esophagectomy similar to United States norms, but lower pooled scores for physical function, vitality and general health perception. The analysis of HRQL conducted using the Global EORTC C30 global scale during a 6-mo follow-up showed that global scale and physical function were better at the baseline. The symptom scales indicated worsened fatigue, dyspnea and diarrhea 6 mo after esophagectomy. In contrast, however, emotional function had significantly improved after 6 mo. In conclusion, short- and long-term HRQL is deeply affected after esophagectomy for cancer. The impairment of physical function may be a long-term consequence of esophagectomy involving either the respiratory system or the alimentary tract. The short- and long-term improvement in the emotional function of patients who have undergone successful operations may be attributed to the impression that they have survived a near-death experience.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; European Organization for Research and Treatment of Cancer OES18; European Organization for Research and Treatment of Cancer QLQ C30; Health-related quality of life; Short form 36

Mesh:

Year:  2011        PMID: 22180708      PMCID: PMC3233672          DOI: 10.3748/wjg.v17.i42.4660

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

1.  Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone.

Authors:  J V Reynolds; R McLaughlin; J Moore; S Rowley; N Ravi; P J Byrne
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

2.  Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer.

Authors:  Robert J Moraca; Donald E Low
Journal:  Arch Surg       Date:  2006-06

3.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

4.  Quality of life during potentially curative treatment for locally advanced oesophageal cancer.

Authors:  K N L Avery; C Metcalfe; C P Barham; D Alderson; S J Falk; J M Blazeby
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

5.  Malnutrition after oesophageal cancer surgery in Sweden.

Authors:  L Martin; J Lagergren; M Lindblad; I Rouvelas; P Lagergren
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

6.  Outcomes after transhiatal and transthoracic esophagectomy for cancer.

Authors:  Andrew C Chang; Hong Ji; Nancy J Birkmeyer; Mark B Orringer; John D Birkmeyer
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

7.  Health-related quality of life among patients cured by surgery for esophageal cancer.

Authors:  Pernilla Lagergren; Kerry N L Avery; Rachael Hughes; C Paul Barham; Derek Alderson; Stephen J Falk; Jane M Blazeby
Journal:  Cancer       Date:  2007-08-01       Impact factor: 6.860

8.  A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.

Authors:  F Bonnetain; O Bouché; P Michel; C Mariette; T Conroy; D Pezet; B Roullet; J-F Seitz; B Paillot; P Arveux; C Milan; L Bedenne
Journal:  Ann Oncol       Date:  2006-03-08       Impact factor: 32.976

9.  Comprehensive investigations of quality of life after esophagectomy with special reference to the route of reconstruction.

Authors:  Masanobu Nakajima; Hiroyuki Kato; Tatsuya Miyazaki; Minoru Fukuchi; Ryokuhei Manda; Norihiro Masuda; Makoto Sohda; Yoichi Kamiyama; Toshihiro Nakabayashi; Erito Mochiki; Hiroyuki Kuwano
Journal:  Hepatogastroenterology       Date:  2007 Jan-Feb

10.  Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy.

Authors:  A P Barbour; P Lagergren; R Hughes; D Alderson; C P Barham; J M Blazeby
Journal:  Br J Surg       Date:  2008-01       Impact factor: 6.939

View more
  50 in total

1.  Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.

Authors:  Linda O'Neill; Jonathan Moran; Emer M Guinan; John V Reynolds; Juliette Hussey
Journal:  J Cancer Surviv       Date:  2018-05-23       Impact factor: 4.442

2.  Compliance with preoperative oral nutritional supplements in patients at nutritional risk--only a question of will?

Authors:  F Grass; P C Bertrand; M Schäfer; P Ballabeni; Y Cerantola; N Demartines; M Hübner
Journal:  Eur J Clin Nutr       Date:  2015-01-21       Impact factor: 4.016

3.  Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.

Authors:  Norma B Bulamu; Gang Chen; Julie Ratcliffe; Ann Schloite; Tim Bright; David I Watson
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

4.  Impact of jejunostomy during esophagectomy for cancer on health related quality of life.

Authors:  Marco Scarpa; Francesco Cavallin; Giulia Noaro; Eleonora Pinto; Rita Alfieri; Matteo Cagol; Carlo Castoro
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

Review 5.  The contemporary role of minimally invasive esophagectomy in esophageal cancer.

Authors:  Mohan K Mallipeddi; Mark W Onaitis
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

Review 6.  Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes.

Authors:  Danica N Giugliano; Adam C Berger; Ernest L Rosato; Francesco Palazzo
Journal:  Langenbecks Arch Surg       Date:  2016-07-11       Impact factor: 3.445

7.  Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome.

Authors:  Anna Pozza; Francesca R Erroi; Marco Scarpa; Lino Polese; Luigi Rampazzo; Lorenzo Norberto
Journal:  Updates Surg       Date:  2015-01-28

Review 8.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

9.  Ivor-Lewis oesophagogastrectomy with Roux-en-Y duodenal bypass.

Authors:  J Cartwright; E Forbat; A Botha
Journal:  Ann R Coll Surg Engl       Date:  2016-01-07       Impact factor: 1.891

10.  Patient experiences of a physiotherapy-led multidisciplinary rehabilitative intervention after successful treatment for oesophago-gastric cancer.

Authors:  A E Bennett; L O'Neill; D Connolly; E M Guinan; L Boland; S L Doyle; J O'Sullivan; J V Reynolds; J Hussey
Journal:  Support Care Cancer       Date:  2018-02-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.